Brief: Basilea Raised Gross Proceeds Of CHF 45.75 Million
Feb 24 (Reuters) - BASILEA PHARMACEUTICA AG BSLN.S :
* BASILEA SUCCESSFULLY PLACED 1 MILLION NEW REGISTERED
SHARES,
RAISING GROSS PROCEEDS OF CHF 45.75 MILLION
Source text for Eikon: ID:nGNE2Z8BbR
Further company coverage: BSLN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Basilea Pharmaceutica AG, Allschwil
See all newsBrief: Basilea Pharmaceutica - Strong Cresemba Sales In Europe Trigger USD 37.5 Mln Milestone Payment
Basilea seen up after raising 2026 guidance
Brief: Basilea Expects 2026 Operating Profit Of CHF 115 Mln
Brief: Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments